qz
Esperion Therapeutics is being taken private by ARCHIMED in a $1.1 billion deal

Shareholders will receive $3.16 per share in cash at closing — a 58% premium — plus contingent payments of up to $100 million [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
Private Internet Access VPN review: Both more and less than a budget VPN

I came into this review thinking of Private Internet Access (PIA) as one of the better VPNs. It's in the Kape Technologies portfolio, along with the top-tier ExpressVPN and the generally reliable [...]

Match Score: 149.29

thenextweb
Cambridge biotech STORM Therapeutics raises $56M

STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by e [...]

Match Score: 40.15

venturebeat
Google’s Gemini can now run on a single air-gapped server — and vanish when you pull the plug

Cirrascale Cloud Services today announced it has expanded its partnership with Google Cloud to deliver the Gemini model on-premises through Google Distributed Cloud, making it the first neocloud provi [...]

Match Score: 38.95

venturebeat
Anthropic says it hit a $30 billion revenue run rate after 'crazy' 80x growth

Dario Amodei is not the kind of CEO who talks loosely about numbers. The Anthropic co-founder and chief executive, a former VP of research at OpenAI with a PhD in computational neuroscience from Princ [...]

Match Score: 35.47

thenextweb
UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease

The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseas [...]

Match Score: 34.07

Destination
Viking Therapeutics closer to bringing its Ozempic competitor to market

Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm.Read more... [...]

Match Score: 33.37

venturebeat
Cerebras stock nearly doubles on day one as AI chipmaker hits $100 billion — what it means for AI infrastructure

Cerebras Systems, the Silicon Valley chipmaker that built the world's largest commercial AI processor, erupted onto the Nasdaq on Wednesday, opening at $350 per share — nearly double its $185 I [...]

Match Score: 29.11

Destination
Black Friday subscription and streaming deals include huge savings on HBO Max, Apple TV+, MasterClass, Rosetta Stone and more

I love locking in a cheap subscription deal during a discount period like Black Friday or Cyber Monday. It always feels like I've gotten away with something — for the rest of the year, I can re [...]

Match Score: 27.96

venturebeat
Microsoft and OpenAI gut their exclusive deal, freeing OpenAI to sell on AWS and Google Cloud

Microsoft and OpenAI on Monday announced a sweeping overhaul of the partnership that has defined the commercial AI era, dismantling key pillars of exclusivity and revenue-sharing that bound the two co [...]

Match Score: 27.27